[HTML][HTML] The role of imaging in current treatment strategies for pancreatic adenocarcinoma

H Rhee, MS Park - Korean Journal of Radiology, 2021 - ncbi.nlm.nih.gov
In pancreatic cancer, imaging plays an essential role in surveillance, diagnosis, resectability
evaluation, and treatment response evaluation. Pancreatic cancer surveillance in high-risk …

Pancreatic cancer, radiomics and artificial intelligence

L Marti-Bonmati, L Cerdá-Alberich… - The British Journal of …, 2022 - academic.oup.com
Patients with pancreatic ductal adenocarcinoma (PDAC) are generally classified into four
categories based on contrast-enhanced CT at diagnosis: resectable, borderline resectable …

CT radiomic features of superior mesenteric artery involvement in pancreatic ductal adenocarcinoma: a pilot study

F Rigiroli, J Hoye, R Lerebours, KJ Lafata, C Li… - Radiology, 2021 - pubs.rsna.org
Background Current imaging methods for prediction of complete margin resection (R0) in
patients with pancreatic ductal adenocarcinoma (PDAC) are not reliable. Purpose To …

Preoperative CT classification of the resectability of pancreatic cancer: interobserver agreement

I Joo, JM Lee, ES Lee, JY Son, DH Lee, SJ Ahn… - Radiology, 2019 - pubs.rsna.org
Background Accurate assessment of local resectability of pancreatic cancer at initial workup
is critical to determine the most appropriate management strategy among up-front operation …

DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT …

J Yao, Y Shi, K Cao, L Lu, J Lu, Q Song, G Jin… - Medical image …, 2021 - Elsevier
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and carries a
dismal prognosis of∼ 10% in five year survival rate. Surgery remains the best option of a …

Estimating recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma by using pancreatic CT: development and validation of a risk …

DW Kim, SS Lee, SO Kim, JH Kim, HJ Kim, JH Byun… - Radiology, 2020 - pubs.rsna.org
Background No preoperative model is available for predicting postsurgical prognosis of
patients with resectable pancreatic ductal adenocarcinoma (PDAC). Purpose To develop …

CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy

JK Jang, JH Byun, JH Kang, JH Son, JH Kim… - European …, 2021 - Springer
Objectives We aimed to assess the ability of CT-determined resectability, as defined by a
recent version of NCCN criteria, and associated CT findings to predict margin-negative (R0) …

Effect of deep learning image reconstruction in the prediction of resectability of pancreatic cancer: diagnostic performance and reader confidence

P Lyu, B Neely, J Solomon, F Rigiroli, Y Ding… - European journal of …, 2021 - Elsevier
Objective To assess the diagnostic performance and reader confidence in determining the
resectability of pancreatic cancer at computed tomography (CT) using a new deep learning …

Neoadjuvant‐modified FOLFIRINOX vs nab‐paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved …

AR Wolfe, D Prabhakar, VO Yildiz, JM Cloyd… - Cancer …, 2020 - Wiley Online Library
We conducted an institutional study to compare the clinical and pathological efficacy
between the neoadjuvant therapy (NAT)‐modified FOLFIRINOX (mFOLF) vs nanoparticle …

[HTML][HTML] Setting the research agenda for clinical artificial intelligence in pancreatic adenocarcinoma imaging

M Schuurmans, N Alves, P Vendittelli, H Huisman… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers
worldwide, associated with a 98% loss of life expectancy and a 30% increase in disability …